ThisDay — Nigeria’s most widely read national newspaper — cited Ash Biomedical Diagnostics Ltd as a trailblazer in the country’s emerging local diagnostics manufacturing sector.
The article, written in response to the national debate around GSK’s exit from Nigeria, noted that companies like Ash Biomedical “stand alone” in developing and manufacturing affordable, high-quality in-vitro diagnostics (IVDs) within Nigeria. The piece highlighted Ash Biomedical’s regulatory approvals and commitment to international quality standards as evidence that local manufacturing is not a pipe dream — it is already happening.